Product Information

METHOTREXATE 2.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1689 per EA under NDC 00555057235. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Oct 15, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHOTREXATE 2.5 MG TABLET

Methotrexate
$0.1689per EA

Strength

2.5 mg/1

NDC

00555057235

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METHOTREXATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA081099

FDA Approved

10/15/1990

TE Code

AB

On Market Since

11/1/1990

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price Statistics

The NADAC for METHOTREXATE 2.5 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 92.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1689 per EA
All-time high$2.2433 (Dec 11, 2013)
All-time low$0.1507 (May 22, 2024)
52-week high$0.1689
52-week low$0.1530
Median price$0.5273
Average price$0.7284
Largest weekly change+41.4% (Jun 19, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+3.5%

1M

+7.1%

3M

+7.9%

6M

+3.0%

1Y

+10.4%

3Y

-25.5%

5Y

-42.2%

All

-92.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHOTREXATE 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHOTREXATE 2.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1689 per EA (NDC 00555057235), effective Nov 18, 2026.

How has the price of METHOTREXATE 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHOTREXATE 2.5 MG TABLET has declined 92.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METHOTREXATE 2.5 MG TABLET?

Since Nov 28, 2013, the NADAC for METHOTREXATE 2.5 MG TABLET has ranged from a low of $0.1507 (May 22, 2024) to a high of $2.2433 (Dec 11, 2013), with a median of $0.5273 per EA.

Are there cheaper alternatives to METHOTREXATE 2.5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHOTREXATE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHOTREXATE 2.5 MG TABLET?

METHOTREXATE 2.5 MG TABLET (NDC 00555057235) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.